CE Unterburg Raises Cytyc to 'Buy'

Analyst Al Kildani says the acquisition of Novacept establishes Cytyc as a women's healthcare franchise

CE Unterburg upgraded Cytyc (CYTC ) to long-term buy from long-term market perform. On Monday, the company announced plans to buy Novacept.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.